Non PE group (n=74) PE group (n=13) p
Age, mean ±SD 66.5 ±11.10 70.77 ± 12.33 0.212
PE risk factors, n (%) 31 (41.9%) 7 (53.8) 0.307
Cancer history, n (%) 10 (13.5) 3 (23.1) 0.3
GOLD III and IV, n (%) 47 (64.4%) 9 (69.2%) 0.552
FEV1 (% pred), mean±SD 41.6 ±17.1 47.1 ±15.9 0.28
Intensive care unit, n (%) 35 (48.6%) 9 (69.2%) 0.143
Wells score, mean± SD 4.42± 1.29 5.23 ± 1.23 0.04
Wells score higher than 5, n (%) 14 (18.9) 6 (46.2) 0.04
Geneve score, mean ± SD 4.68 ± 1.68 5.23± 1.59 0.278
Increased cough, n (%) 50 (67.6%) 3 (23.1%) 0
Increased sputum volume, n (%) 47 (63.5%) 6 (46.2%) 0.19
Chest pain, n (%) 9 (12.2%) 2 (15.4%) 0.517
D Dimer (µg/mL), mean± SD 1.50±0.98 2.24±1.16 0.02
PaO2/FiO2ratio, mean±SD 242.9±73.9 263.1±106.9 0.439
PaCO2 (mmHg) mean±SD 54.53±20.06 46.72±14.49 0.183
Lactate (mmol/L), mean±SD 1.82±0.99 1.82±0.45 0.992
pH, mean±SD 7.34±0.99 7.36±0.83 0.479
CRP (mg/mL), mean±SD 70.87±74.88 61.38±97.15 0.688
Troponin (ng/mL), mean±SD 0.14±0.54 0.22±0.29 0.62
BNP (ng/mL), mean±SD 350.57±474.27 343.40±336.98 0.964
PE=Pulmonary Embolism. FEV1=Forced Expiratory Volume in 1 second. CRP=C Reactive Protein. BNP=B Natriuretic Protein.
Table 2: Comparisons of anthropometric, clinical, functional and biological data between patients with pulmonary embolism (PE group, N=13) and patients without pulmonary embolism (Non PE-group, N=74).